iBio
IBIO
$1.99
Share price
-1.97%
Change (1 day)
82.57%
Change (1 year)
Categories
P/S ratio for iBio (IBIO)
P/S ratio as of May 2024 (TTM): 350
According to iBio's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 349.625. At the end of 2023 the company had a P/S ratio of 54.9.
P/S ratio history for iBio from 2008 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 54.9 | 2455.43% |
| 2022 | 2.15 | -97.59% |
| 2021 | 89.3 | -6.39% |
| 2020 | 95.4 | 1124.4% |
| 2019 | 7.79 | -52.51% |
| 2018 | 16.4 | -63.13% |
| 2017 | 44.5 | 9.22% |
| 2016 | 40.7 | -9.78% |
| 2015 | 45.2 | 27.38% |
| 2014 | 35.4 | 1.28% |
| 2013 | 35.0 | 31.55% |
| 2012 | 26.6 | 6.34% |
| 2011 | 25.0 | |
| 2010 | N/A | -100% |
| 2009 | 54.8 | 2615.61% |
| 2008 | 2.02 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 3.88 | -98.89% | 🇺🇸 USA |
 Genocea Biosciences
GNCA | 0.0031 | -100.00% | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | 3.40 | -99.03% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | 0.1689 | -99.95% | 🇺🇸 USA |